|
ASX - By Stock
|
EGR |
Re:
EGR - what do we need to tick off now?
|
|
Dilmac
|
44 |
15K |
1 |
08/04/25 |
| 08/04/25 |
ASX - By Stock
|
44
|
15K
|
1
|
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Trading Halt
|
|
Dilmac
|
97 |
35K |
13 |
03/04/25 |
| 03/04/25 |
ASX - By Stock
|
97
|
35K
|
13
|
|
|
ASX - By Stock
|
TLX |
Re:
Telix ASX TLX Breaking News & Current Commentary
|
|
Dilmac
|
6.4K |
2.3M |
4 |
02/04/25 |
| 02/04/25 |
ASX - By Stock
|
6.4K
|
2.3M
|
4
|
|
|
ASX - By Stock
|
TLX |
Re:
Common Sense Required
|
|
Dilmac
|
16 |
6.7K |
3 |
01/04/25 |
| 01/04/25 |
ASX - By Stock
|
16
|
6.7K
|
3
|
|
|
ASX - By Stock
|
APE |
Fill the Gap
|
|
Dilmac
|
0 |
370 |
0 |
31/03/25 |
| 31/03/25 |
ASX - By Stock
|
0
|
370
|
0
|
|
|
ASX - By Stock
|
TLX |
Re:
Telix ASX TLX Breaking News & Current Commentary
|
|
Dilmac
|
6.4K |
2.3M |
4 |
31/03/25 |
| 31/03/25 |
ASX - By Stock
|
6.4K
|
2.3M
|
4
|
|
|
ASX - By Stock
|
ABB |
Re:
Ann: Update - Notification of buy-back - ABB
|
|
Dilmac
|
6 |
2.2K |
0 |
25/03/25 |
| 25/03/25 |
ASX - By Stock
|
6
|
2.2K
|
0
|
|
|
ASX - By Stock
|
ABB |
Re:
Ann: Update - Notification of buy-back - ABB
|
|
Dilmac
|
6 |
2.2K |
0 |
25/03/25 |
| 25/03/25 |
ASX - By Stock
|
6
|
2.2K
|
0
|
|
|
ASX - By Stock
|
ABB |
Re:
Ann: Update - Notification of buy-back - ABB
|
|
Dilmac
|
6 |
2.2K |
1 |
24/03/25 |
| 24/03/25 |
ASX - By Stock
|
6
|
2.2K
|
1
|
|
|
ASX - By Stock
|
NHC |
Re:
Ann: FY25 Half Year Results & On-Market Share Buy Back
|
|
Dilmac
|
142 |
65K |
3 |
19/03/25 |
| 19/03/25 |
ASX - By Stock
|
142
|
65K
|
3
|
|
|
ASX - By Stock
|
MIN |
Another crash
|
|
Dilmac
|
3 |
1.8K |
0 |
18/03/25 |
| 18/03/25 |
ASX - By Stock
|
3
|
1.8K
|
0
|
|
|
ASX - By Stock
|
SPR |
Re:
Ann: Transformational Combination of Ramelius & Spartan
|
|
Dilmac
|
225 |
105K |
19 |
17/03/25 |
| 17/03/25 |
ASX - By Stock
|
225
|
105K
|
19
|
|
|
ASX - By Stock
|
SPR |
Re:
RMS take over
|
|
Dilmac
|
632 |
274K |
4 |
16/03/25 |
| 16/03/25 |
ASX - By Stock
|
632
|
274K
|
4
|
|
|
ASX - By Stock
|
SPR |
Re:
RMS take over
|
|
Dilmac
|
632 |
274K |
4 |
16/03/25 |
| 16/03/25 |
ASX - By Stock
|
632
|
274K
|
4
|
|
|
ASX - By Stock
|
SPR |
Re:
Cruch time....
|
|
Dilmac
|
329 |
118K |
0 |
16/03/25 |
| 16/03/25 |
ASX - By Stock
|
329
|
118K
|
0
|
|
|
ASX - By Stock
|
SPR |
Re:
Cruch time....
|
|
Dilmac
|
329 |
118K |
0 |
16/03/25 |
| 16/03/25 |
ASX - By Stock
|
329
|
118K
|
0
|
|
|
ASX - By Stock
|
SPR |
Re:
Cruch time....
|
|
Dilmac
|
329 |
118K |
3 |
16/03/25 |
| 16/03/25 |
ASX - By Stock
|
329
|
118K
|
3
|
|
|
ASX - By Stock
|
SPR |
Re:
Cruch time....
|
|
Dilmac
|
329 |
118K |
7 |
16/03/25 |
| 16/03/25 |
ASX - By Stock
|
329
|
118K
|
7
|
|
|
ASX - By Stock
|
JLG |
Re:
Ann: 1H25 Results Announcement
|
|
Dilmac
|
235 |
123K |
1 |
06/03/25 |
| 06/03/25 |
ASX - By Stock
|
235
|
123K
|
1
|
|
|
ASX - By Stock
|
AZY |
Re:
Ann: Lift of Trading Halt
|
|
Dilmac
|
19 |
11K |
11 |
06/03/25 |
| 06/03/25 |
ASX - By Stock
|
19
|
11K
|
11
|
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
Dilmac
|
5.8K |
1.8M |
1 |
03/03/25 |
| 03/03/25 |
ASX - By Stock
|
5.8K
|
1.8M
|
1
|
|
|
ASX - By Stock
|
KAR |
Short Thesis
|
|
Dilmac
|
4 |
2.0K |
6 |
02/03/25 |
| 02/03/25 |
ASX - By Stock
|
4
|
2.0K
|
6
|
|
|
ASX - By Stock
|
TUA |
Re:
SIMBA's Competitor reports
|
|
Dilmac
|
13 |
5.7K |
1 |
28/02/25 |
| 28/02/25 |
ASX - By Stock
|
13
|
5.7K
|
1
|
|
|
ASX - By Stock
|
PWH |
Re:
Ann: Investments delivering outcomes that underpin future growth
|
|
Dilmac
|
17 |
11K |
0 |
21/02/25 |
| 21/02/25 |
ASX - By Stock
|
17
|
11K
|
0
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: INVESTOR PRESENTATION - CAPITAL RAISE
|
|
Dilmac
|
105 |
44K |
7 |
21/02/25 |
| 21/02/25 |
ASX - By Stock
|
105
|
44K
|
7
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: INVESTOR PRESENTATION - CAPITAL RAISE
|
|
Dilmac
|
105 |
44K |
5 |
21/02/25 |
| 21/02/25 |
ASX - By Stock
|
105
|
44K
|
5
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: INVESTOR PRESENTATION - CAPITAL RAISE
|
|
Dilmac
|
105 |
44K |
7 |
21/02/25 |
| 21/02/25 |
ASX - By Stock
|
105
|
44K
|
7
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: INVESTOR PRESENTATION - CAPITAL RAISE
|
|
Dilmac
|
105 |
44K |
11 |
21/02/25 |
| 21/02/25 |
ASX - By Stock
|
105
|
44K
|
11
|
|
|
ASX - By Stock
|
DHG |
Takeover Incoming
|
|
Dilmac
|
19 |
8.8K |
6 |
20/02/25 |
| 20/02/25 |
ASX - By Stock
|
19
|
8.8K
|
6
|
|
|
ASX - By Stock
|
MAF |
Re:
Ann: MA Financial delivers FY24 financial result
|
|
Dilmac
|
3 |
2.2K |
2 |
20/02/25 |
| 20/02/25 |
ASX - By Stock
|
3
|
2.2K
|
2
|
|
|
ASX - By Stock
|
MAF |
Re:
Ann: MA Financial delivers FY24 financial result
|
|
Dilmac
|
3 |
2.2K |
4 |
20/02/25 |
| 20/02/25 |
ASX - By Stock
|
3
|
2.2K
|
4
|
|
|
ASX - By Stock
|
MIN |
Re:
Ann: FY25 Half Year Financial Report and Appendix 4D
|
|
Dilmac
|
378 |
189K |
0 |
19/02/25 |
| 19/02/25 |
ASX - By Stock
|
378
|
189K
|
0
|
|
|
ASX - By Stock
|
MIN |
Re:
Ann: FY25 Half Year Financial Report and Appendix 4D
|
|
Dilmac
|
378 |
189K |
1 |
18/02/25 |
| 18/02/25 |
ASX - By Stock
|
378
|
189K
|
1
|
|
|
ASX - By Stock
|
SNT |
Re:
Ann: SNT drug leads to significant normalisation of skin scarring
|
|
Dilmac
|
67 |
25K |
3 |
18/02/25 |
| 18/02/25 |
ASX - By Stock
|
67
|
25K
|
3
|
|
|
ASX - By Stock
|
MIN |
Re:
Ann: Governance Update
|
|
Dilmac
|
88 |
40K |
0 |
18/02/25 |
| 18/02/25 |
ASX - By Stock
|
88
|
40K
|
0
|
|
|
ASX - By Stock
|
MIN |
Re:
Ann: Governance Update
|
|
Dilmac
|
88 |
40K |
1 |
13/02/25 |
| 13/02/25 |
ASX - By Stock
|
88
|
40K
|
1
|
|
|
ASX - By Stock
|
MIN |
Re:
Ann: Governance Update
|
|
Dilmac
|
88 |
40K |
7 |
13/02/25 |
| 13/02/25 |
ASX - By Stock
|
88
|
40K
|
7
|
|
|
ASX - By Stock
|
CSL |
Re:
Ann: CSL Half Year Results Investor Presentation
|
|
Dilmac
|
102 |
53K |
0 |
11/02/25 |
| 11/02/25 |
ASX - By Stock
|
102
|
53K
|
0
|
|
|
ASX - By Stock
|
NEM |
Re:
Ann: NEM Announces Q4 and YE 2024 Earnings Conference Call
|
|
Dilmac
|
89 |
35K |
1 |
06/02/25 |
| 06/02/25 |
ASX - By Stock
|
89
|
35K
|
1
|
|
|
ASX - By Stock
|
KAR |
Re:
Ann: 2024 Fourth Quarter Report
|
|
Dilmac
|
9 |
6.3K |
8 |
05/02/25 |
| 05/02/25 |
ASX - By Stock
|
9
|
6.3K
|
8
|
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Breakthrough results for endometriosis diagnostic blood test
|
|
Dilmac
|
38 |
16K |
0 |
31/12/24 |
| 31/12/24 |
ASX - By Stock
|
38
|
16K
|
0
|
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Breakthrough results for endometriosis diagnostic blood test
|
|
Dilmac
|
38 |
16K |
4 |
30/12/24 |
| 30/12/24 |
ASX - By Stock
|
38
|
16K
|
4
|
|
|
ASX - By Stock
|
KAR |
Re:
Ann: Bauna Shutdown and Updated Guidance
|
|
Dilmac
|
57 |
29K |
3 |
18/12/24 |
| 18/12/24 |
ASX - By Stock
|
57
|
29K
|
3
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical wins contract with University of Chicago Medicine
|
|
Dilmac
|
68 |
41K |
0 |
16/12/24 |
| 16/12/24 |
ASX - By Stock
|
68
|
41K
|
0
|
|
|
ASX - By Stock
|
TUA |
Re:
Ann: AGM Presentation and Chairman's Address
|
|
Dilmac
|
10 |
5.9K |
3 |
09/12/24 |
| 09/12/24 |
ASX - By Stock
|
10
|
5.9K
|
3
|
|
|
ASX - By Stock
|
MME |
MME breakout
|
|
Dilmac
|
4 |
2.9K |
4 |
09/12/24 |
| 09/12/24 |
ASX - By Stock
|
4
|
2.9K
|
4
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical wins commercial contract with IPOC
|
|
Dilmac
|
137 |
46K |
0 |
05/12/24 |
| 05/12/24 |
ASX - By Stock
|
137
|
46K
|
0
|
|
|
ASX - By Stock
|
PWH |
Re:
Bell and Citi BUYS
|
|
Dilmac
|
3 |
3.5K |
1 |
21/11/24 |
| 21/11/24 |
ASX - By Stock
|
3
|
3.5K
|
1
|
|
|
ASX - By Stock
|
PWH |
Bell and Citi BUYS
|
|
Dilmac
|
3 |
3.5K |
3 |
21/11/24 |
| 21/11/24 |
ASX - By Stock
|
3
|
3.5K
|
3
|
|
|
ASX - By Stock
|
MIN |
Re:
Ann: Response to ASX Compliance Letter
|
|
Dilmac
|
115 |
62K |
13 |
20/11/24 |
| 20/11/24 |
ASX - By Stock
|
115
|
62K
|
13
|
|